ProfessorPaulo Ferreira

Research Leadership at the University of Sydney

Professor Ferreira is Research Academic Director, Faculty of Medicine and Health; Founding Director, Musculoskeletal Research Hub, Charles Perkins Centre, University of Sydney.

Professor Paulo Ferreira is a globally recognised expert in musculoskeletal health, ranked #1 in the world for research on low back pain and physical activity (Web of Science, 2025). He leads the Musculoskeletal Research Hub at the Charles Perkins Centre, a multidisciplinary team of over 35 researchers within one of Australia’s largest research centres.

Prof Ferreira’s work has driven a paradigm shift in the management of back pain, challenging ineffective treatments such as pain medications and spinal injections. His research has informed 30+ clinical guidelines across 19 countries, contributed to 16+ deprescribing tools, and shaped major policy changes including the 2020 WHO guidelines and Australian Clinical Care Standards. With over 294 publications and 26,000+ citations, his work appears in top-tier journals like The Lancet, BMJ, and Annals of Internal Medicine. His research has received prestigious awards, including the highest-ranked NHMRC Career Development Industry Fellowship, and has been featured in global media outlets such as The Washington Post and The New York Times.

Prof Ferreira has secured over $20 million in research funding from national and international agencies, and currently leads a major NHMRC-funded initiative to establish Australia’s first national helpline for low back pain. His implementation trials are co-designed with consumer groups, rural health organisations, and government bodies, ensuring real-world impact and relevance.

Leadership Profile

RESEARCH MENTORING

Since 2015, Professor Ferreira has supervised 19 PhD and 12 Honours students to completion (career: 24 PhDs, 33 Hons, 9 Masters). He currently supervise 2 post-docs, 8 PhDs, 1 Masters, 1 Honours. All 24 PhD students completed on time and 15 held scholarships. Because He is multilingual, He is highly successful in supporting PhD students who speak English as a 2^nd language (15 of the 24 students).

He encourages the success of his students by listing them as first authors on manuscripts, developing their grant skills, and placing them on large international collaborative projects (eg. Ho, Roberts, Zouch are AIs on 2023/24/25 NHMRC partnership grants APPs1180474, 2031038, 2040570).

His students’ exceptional career outcomes testify to his outstanding supervisory skills. Three of his PhD graduates have been awarded NHMRC fellowships (2 ECFs, 1 IG), and 2 awarded international fellowships (UofA Canada; CNPQ Brazil). They have been awarded prizes for best research in conferences [International Low Back Pain (LBP) Conference 2023] and journals (eg. BMJ Most accessed paper in 2015), and featured in national and international media (eg. NY Times, 2015).

In recognition of the strong emphasis He places on supporting the success of his students He was awarded the USYD Postgraduate Research Association supervisor of the year award in 2020, and the USYD Vice-Chancellor’s Award for outstanding research supervisor in 2021.

One of his core principles is to ensure his mentees are given opportunities to excel, including providing strategic advice and reviewing their grant applications. Of his 5 mid-career mentees at USYD, 1 secured a NHMRC Investigator Grant (EL1), 1 secured MRFF ECR funding as CIA (I was AI; $4.7M), 2 were promoted to Level D, and 1 secured NHMRC Project funding (CIA). In the LBP field He has mentored 5 of the top 0.1% experts (~50) in Expertscape (among 14,962). Their research has been featured in leading international media (eg. The Guardian/UK, 2015).  

RESEARCH PROGRAMS TEAM LEADERSHIP

From the outset of his research career, Professor Ferreira has driven by the need to elucidate the causes and implement effective management for LBP. He has consistently pursued this goal, resulting in a program with exceptional reputation nationally and internationally.

Since 2015 He has secured >$28M in funding, including NHMRC partnership grants, CRE, CDF, Project grants, MRFF CTAs, and international grants (eg. USA, Spain, Brazil). In the past 5 years He has secured >22M in NHMRC/MRFF funding as CIA/CIB or mentor of my ECRs on MRFF ECR grants: 4 NHMRC partnerships, 1 NHMRC CTCS, 3 MRFF CTAs grants. He has conceptualised, funded, and led two world leading (most published) programs in LBP (Web of Science, Jun 2025): A twin program (46 studies), and a physical activity program (99 studies).

He leads a culturally diverse team of 2 post-docs, 8 PhDs, 1 Honours, and 6 research staff. His team has discovered causes for LBP (eg. poor sleep), revealed the effectiveness of innovative treatments (eg. e-health exercises), and established the limited effects of common treatments (eg. paracetamol). He has developed new models to support patients after discharge from treatment (NHMRC Partnership–CIA), e-health solutions for LBP in remote Australia (Medibank funded trial–CIA), national Help Lines for LBP (NHMRC Partnership–CIA), and physiotherapists as first contact practitioners for LBP (NHMRC Partnership–CIA). In recognition of his leadership He was awarded the USYD Outstanding Research Award in 2025. 

Over 85% (Scival Jun 2025) of Professor Ferreira’s publications (eg. CODATwins 2019: 110 researchers, 24 countries) include international authors from 25+ countries (eg. UK, Norway, Japan, South Africa). He is 1 of 3 international LBP leaders of the Global Burden of Disease project (253 international members) which monitors the global impact of LBP (LANCET Rheumatology, 2023; 1000+ citations in 2 years). The project’s outcomes have informed the 2024 WHO guidelines for LBP, and the 2023 UNESCO physical activity report.

RESEARCH POLICY AND PROFESSIONAL LEADERSHIP

As a board member of the most influential LBP global scientific network (the 31-international member LBP Forum), Professor Ferreira has significantly influenced major policy changes in LBP internationally including the 2020 UK Academy Medical Royal Colleges review of spinal surgeries. In that role He organised the 2014 International LBP conference. A significant outcome of this meeting, which He chaired, was the commission of the Lancet global action on LBP (I co-authored 3 Lancet papers; total 9,062 citations).

As an advocate for change in health policy nationally and abroad He is a regular media commentator. For example: his NHMRC (APP1003308) TRIGGERs study featured in Le Figaro France (2015); his trial of videogame exercises was reported in Eastday News China (2019); his study of LBP & mortality featured in The Daily Mirror UK, Fox News US, and his 2023 BMJ Network Meta Analysis is in the top 5% of all research outputs ever tracked by Altmetric, reaching an audience of >700k people worldwide (USYD Media 2023).

Recognised as Australia’s #1 author in the field of clinician-patient interactions in LBP (Web of Science Jun 2025) He provides input to the Australian Physiotherapy Association (APA)’s development of educational resources on clinician-patient communication used to train >29,000 physiotherapists nationwide. He also advises the APA on an innovative care model of physiotherapists as first contact practitioners for LBP in Australia.

As a trusted LBP expert, He advises the Musculoskeletal Health Australia (main consumer organisation advocating for people with LBP) on the implementation of their new LBP Help Line, and the NSW Agency for Clinical Innovation on new models of LBP care.

Professor Ferreira advised the NHMRC Research Translation Group (2014/19), was a member of the NHMRC CTCS (2012/20) and partnership (2022/now) grant panels, is an Editorial Board member of an international Journal [PTJ (2021/now)], and the Cochrane LBP group (2012/18).

INSTITUTIONAL LEADERSHIP

Professor Ferreira’s leadership contributions at my University include leading two highly-impactful research programs, managing research training, and providing high level institutional research advice and leadership. 

He leads the research strategy and training of the University of Sydney (USYD) Musculoskeletal Flagship Centre – a university-funded research initiative ($900K p.a.). The flagship is ranked #1 in Australia (#7 globally), and is the most successful musculoskeletal collaborative network (Expertscape Jun 2025): 375 members, total funds of $61 million; 3,059 publications.

He is founding director of the musculoskeletal research Hub (35+ members) at the Charles Perkins Centre (CPC). The CPC is a $500M USYD Multidisciplinary Initiative research centre with 1,005 research members. His work as a mentor and my collaborative leadership style were instrumental in the Hub’s notable success: >$30M in total NHMRC grants, four staff hold NHMRC fellowships, and 2 are in the 2021 world Clarivate Analytics Highly Cited Researchers List (Baumann A, Maher C). Each Hub member of the professoriate is in the top 0.1% of their field globally (Expertscape Jun 2025).

As a Research Director (2022-current) of the Faculty of Medicine and Health (FMH) at USYD, He oversees the faculty’s research performance, strategy, and culture. Under his leadership competitive research income for the faculty has increased by 9.3% per year. In his role, He supervises, advises, and implements research initiatives to enable 3,000+ researchers across 7 Research Flagship centres, 4 Impact centres, 12 research networks, and 6 Multidisciplinary Centres to excel. For example, He has implemented a FMH Grant Peer Review Academy, with his leadership being instrumental for the faculty’s research success: In 2024, the faculty was awarded $40M by the NHMRC in the Investigator scheme, $21M in the Ideas Grants scheme, and $67M by Department of Health in MRFF Funding.